124 related articles for article (PubMed ID: 10067990)
1. Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes.
Das A; McGuire PG; Eriqat C; Ober RR; DeJuan E; Williams GA; McLamore A; Biswas J; Johnson DW
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):809-13. PubMed ID: 10067990
[TBL] [Abstract][Full Text] [Related]
2. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
Gendron RL; Good WV; Adams LC; Paradis H
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
[TBL] [Abstract][Full Text] [Related]
3. Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy.
Webster L; Chignell AH; Limb GA
Exp Eye Res; 1999 Jan; 68(1):91-8. PubMed ID: 9986746
[TBL] [Abstract][Full Text] [Related]
4. Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor.
Das A; McLamore A; Song W; McGuire PG
Arch Ophthalmol; 1999 Apr; 117(4):498-503. PubMed ID: 10206578
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.
Kon CH; Occleston NL; Charteris D; Daniels J; Aylward GW; Khaw PT
Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1524-9. PubMed ID: 9660504
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
7. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
[TBL] [Abstract][Full Text] [Related]
8. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation.
Snead DR; James S; Snead MP
Eye (Lond); 2008 Oct; 22(10):1310-7. PubMed ID: 18344963
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
Teesalu T; Masson R; Basset P; Blasi F; Talarico D
Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases in human diabetic and nondiabetic vitreous.
Jin M; Kashiwagi K; Iizuka Y; Tanaka Y; Imai M; Tsukahara S
Retina; 2001; 21(1):28-33. PubMed ID: 11217926
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
Pei XH; Nakanishi Y; Takayama K; Bai F; Hara N
Br J Cancer; 1999 Jan; 79(1):40-6. PubMed ID: 10408691
[TBL] [Abstract][Full Text] [Related]
12. Cyclo-oxygenase-2 expression in human idiopathic epiretinal membrane.
Kase S; Saito W; Ohno S; Ishida S
Retina; 2010 May; 30(5):719-23. PubMed ID: 19996819
[TBL] [Abstract][Full Text] [Related]
13. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
[TBL] [Abstract][Full Text] [Related]
14. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
Forsyth PA; Wong H; Laing TD; Rewcastle NB; Morris DG; Muzik H; Leco KJ; Johnston RN; Brasher PM; Sutherland G; Edwards DR
Br J Cancer; 1999 Apr; 79(11-12):1828-35. PubMed ID: 10206300
[TBL] [Abstract][Full Text] [Related]
15. [The specificity of the ultrastructural pattern of neoplastic vessels of the retina in diabetic retinopathy].
Sdobnikova SV; Chekmareva IA; Fedorov AA; Mazurina NK; Kochetkova EA
Vestn Oftalmol; 2005; 121(1):25-9. PubMed ID: 15759844
[TBL] [Abstract][Full Text] [Related]
16. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R
Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy.
Yang R; Liu H; Williams I; Chaqour B
Ann N Y Acad Sci; 2007 Apr; 1103():196-201. PubMed ID: 17332085
[TBL] [Abstract][Full Text] [Related]
19. TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy.
Yamaji Y; Yoshida S; Ishikawa K; Sengoku A; Sato K; Yoshida A; Kuwahara R; Ohuchida K; Oki E; Enaida H; Fujisawa K; Kono T; Ishibashi T
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3151-7. PubMed ID: 18316703
[TBL] [Abstract][Full Text] [Related]
20. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]